🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07442864
Recruiting Not applicable

Hunger Perception and Weight-Related Outcomes Following Use of a Leptin-Supporting Dietary Supplement

NCT07442864 · tracked via the Priya Life Science USA tracker
Sponsor
Efforia, Inc
Phase
Not applicable
Started
2025-09-10
Last updated
2026-03-02

Condition(s) studied

HungerWeight Change

Investigational drug(s) / intervention(s)

Leptin Balance Formula

Leptin Balance Formula: Participants will self-administer the Leptin Balance Formula daily for 12 weeks according to product labeling. The supplement is commercially available and includes African mango seed extract, chromium picolinate, Ceylon cinnamon, and alpha lipoic acid.

Study summary

This study evaluates changes in hunger perception and body composition-related measures following daily use of a commercially available dietary supplement formulated to support leptin-related metabolic signaling. Adult participants will self-administer the supplement for 12 weeks and complete periodic self-reported assessments related to appetite, hunger, and weight-related outcomes. Participants serve as their own control, with comparisons made between baseline and follow-up measurements. The study is designed to generate preliminary, real-world evidence regarding supplement use in a general wellness context.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged 18 years or older * Willing to pay for study supplies and able to take the dietary supplement daily for 12 weeks * Willing to complete electronic questionnaires and self-reported measurements * Able to provide informed consent Exclusion Criteria: * Pregnant or breastfeeding individuals * Known allergy or sensitivity to any supplement ingredients * Use of medications or supplements that could interfere with appetite or weight without medical clearance * Any medical condition that would make participation unsafe, as determined by the participant

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Efforia New York New York Recruiting

More Efforia, Inc trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07442864 on ClinicalTrials.gov ↗ ← All trials in the USA